
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic inflammatory diseases and health-related conditions, with significant expertise in metabolism and inflammation. The products empower individuals and their healthcare providers to manage prevention and treatment of chronic diseases through genetics-based insights and actionable guidance. Interleukin Genetics lead products include its proprietary ILUSTRATM Inflammation Management Program and its Inherent Health line of genetic tests. Key Products: ILUSTRATM Inflammation Management Program Uses a simple, oral cheek swab sample to accurately measure variations in the genes for Interleukin-1 (IL-1), a key regulator of inflammation, which can lead to chronic disease,...
Genetic testing,biomarkers,wellness,and inflammation
Interleukin genetics operates in the Biotechnology research industry.
Interleukin genetics's revenue is 1m - 10m
Interleukin genetics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.